The nation of Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive information.
The decision became public after a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesman later explained that the US was seeking genetic material for research and commercial purposes but refused to guarantee the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to find a agreement suitable to both sides so the country's critical HIV programme can be sustained.
Broader Implications
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a court blocked a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
As per statements, Sixteen African countries have to date agreed to these new agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our people if a new pandemic emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining systems previously established via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This framework is designed to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how future co-operation could be arranged in a manner that honours the independence and interests of each country."
Health Experts Response
A leading public health body stated it understood the official position, but recommended that negotiations should continue considering a large portion of the nation's HIV programmes depended on external financing.
"Where technical issues arise, such as those relating to data governance or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group added.
The halted deal highlights the ongoing debate between accepting crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.